104 related articles for article (PubMed ID: 29779317)
1. [The expression of KLK7 in pancreatic cancer and the effects on the biological behavior of pancreatic cancer cells].
Zheng SL; Feng MY; Yang G; Xiong GB; Zheng LF; Zhang TP; Zhao YP
Zhonghua Wai Ke Za Zhi; 2018 May; 56(5):391-397. PubMed ID: 29779317
[No Abstract] [Full Text] [Related]
2. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
[TBL] [Abstract][Full Text] [Related]
3. [The long coding RNA GSTM3TV2 acts an oncogene to promote chemoresistance in pancreatic cancer].
Xiong GB; Yang G; Feng MY; Zhao FY; Zheng LF; Zhang TP; Zhao YP
Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):691-697. PubMed ID: 31474062
[No Abstract] [Full Text] [Related]
4. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
5. [Correlation between miR-1178 expression and clinicopathological significance in human pancreatic cancer].
Cao Z; Zheng SL; Yang G; Feng MY; Zheng LF; Zhang TP; Zhao YP
Zhonghua Wai Ke Za Zhi; 2017 Jun; 55(6):468-473. PubMed ID: 28592083
[No Abstract] [Full Text] [Related]
6. Expression of KLF9 in pancreatic cancer and its effects on the invasion, migration, apoptosis, cell cycle distribution, and proliferation of pancreatic cancer cell lines.
Zhong Z; Zhou F; Wang D; Wu M; Zhou W; Zou Y; Li J; Wu L; Yin X
Oncol Rep; 2018 Dec; 40(6):3852-3860. PubMed ID: 30542730
[TBL] [Abstract][Full Text] [Related]
7. Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer.
Walker F; Nicole P; Jallane A; Soosaipillai A; Mosbach V; Oikonomopoulou K; Diamandis EP; Magdolen V; Darmoul D
Biol Chem; 2014 Sep; 395(9):1075-86. PubMed ID: 25153388
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of leukemia inhibitory factor in human pancreatic cancer].
Peng F; Zhou J; Sheng W; Zhang D; Dong M
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):90-5. PubMed ID: 24721346
[TBL] [Abstract][Full Text] [Related]
9. ProNGF siRNA inhibits cell proliferation and invasion of pancreatic cancer cells and promotes anoikis.
Xu J; Song J; Yang X; Guo J; Wang T; Zhuo W
Biomed Pharmacother; 2019 Mar; 111():1066-1073. PubMed ID: 30841420
[TBL] [Abstract][Full Text] [Related]
10. [Phospholipase C δ1 (PLCD1) inhibits the proliferation, invasion and migration of CAPAN-1 and BXPC-3 pancreatic cancer cells].
Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jun; 32(6):739-45. PubMed ID: 27371838
[TBL] [Abstract][Full Text] [Related]
11. Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.
Dai H; Chen H; Liu W; You Y; Tan J; Yang A; Lai X; Bie P
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2107-17. PubMed ID: 27444299
[TBL] [Abstract][Full Text] [Related]
12. [Protocadherin 10 (PCDH10) inhibits the proliferation, invasion and migration ability of BXPC-3 pancreatic cancer cells].
Qiu C; Bu X; Hu D; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):163-7. PubMed ID: 26927373
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
[TBL] [Abstract][Full Text] [Related]
14. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4.
Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z
Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
[TBL] [Abstract][Full Text] [Related]
17. A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.
Yang K; He M; Cai Z; Ni C; Deng J; Ta N; Xu J; Zheng J
Pancreas; 2015 Apr; 44(3):370-9. PubMed ID: 25522282
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
19. Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models.
Shinkai K; Nakano K; Cui L; Mizuuchi Y; Onishi H; Oda Y; Obika S; Tanaka M; Katano M
Int J Cancer; 2016 Jul; 139(2):433-45. PubMed ID: 26939718
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1.
Yu C; Wang M; Li Z; Xiao J; Peng F; Guo X; Deng Y; Jiang J; Sun C
Cell Oncol (Dordr); 2015 Jun; 38(3):173-81. PubMed ID: 25875420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
